Advancing Dermatology Together

Corporate and Foundation partners play an integral role in building momentum within our specialty. The knowledge generated through Dermatology Foundation research has led to new and improved treatments.

We’ve seen the results! Foundation-funded research for psoriasis started in the 1980s, and grew over the next 20 years. This ongoing research was moved forward by a major pharmaceutical company and is now considered a standard in patient care. The Foundation's initial investment set the path for this true achievement in patient care.

thisisengineering-raeng-vGA1ei1yxos-unsplash

The partnership between the corporate world and non-profits is vital for continued growth through research and innovation. Corporate grants are a solid investment ensuring the vitality of dermatology.”

Jonathan S. Weiss, MD

Corporate Relations Chair, Executive Committee
Weiss-Headshot1_2020

2024 - 25 Corporate and Foundation Supporters

Every step forward expanding the knowledge of dermatology has the potential to transform lives. The DF is honored to recognize our Partners support in advancing research.

Cornerstone Benefactor

Gifts of $1,000,000 and more

BMY_BIG
Johnson-Johnson-Logo
sanofi-regeneron-logos-rgb-horizontal-1

Platinum

Gifts of $200,000 and more

AbbVie_Inc-Logo
loreal

Gold

Gifts of $100,000 to $199,999

GALDERMA_LOGO_BLACK_RGB
Lilly-Logo.svg
Novartis-Emblem
Ortho-Derm-Logo_4C_NoTM

Silver

Gifts of $50,000 to $99,999

American Academy of Dermatology Pfizer

Hidradenitis Suppurativa Foundation UCB

2025 Clinical Symposia Sponsors

Biofrontera, Inc.

Castle Biosciences

Chiesi Global Rare Diseases

Dermavant Sciences, Inc.

Incyte Corporation

Kyowa Kirin, Inc.

Leo Pharma, Inc.

Sun Pharmaceuticals Industries, Inc.

Verrica Pharmaceuticals

We invest your donations to support and advance the science of skin. 

The Foundation recognizes the importance of strong relationships with our Corporate and Foundation partners and welcomes the opportunity to create customized sponsor opportunities.